Endoscopic third ventriculostomy and ventriculoperitoneal shunting are two surgical approaches to treating hydrocephalus. Both aim to manage excess cerebrospinal fluid, but they work differently. The best option depends on the child's age, anatomy, underlying cause, and medical history.
Understanding the two treatment approaches
Hydrocephalus occurs when cerebrospinal fluid builds up within the brain's ventricles.
Surgery may be necessary when the accumulation threatens neurological function.
A VP shunt diverts fluid away from the ventricles through an implanted device.
Endoscopic third ventriculostomy, or ETV, creates an internal opening that allows CSF to bypass certain obstructions.
Neither procedure is suitable for every patient.
The treatment decision requires specialized evaluation.
How endoscopic third ventriculostomy works
During ETV, a neurosurgeon uses an endoscope to reach the ventricular system.
A small opening is created in the floor of the third ventricle.
This opening allows cerebrospinal fluid to flow toward other spaces where it can circulate.
ETV can be useful when hydrocephalus results from certain internal blockages.
For example, selected patients with aqueductal stenosis may benefit.
However, successful fluid movement through the opening also depends on the body's ability to absorb CSF.
How VP shunts differ
A VP shunt uses an implanted catheter and valve system.
Fluid is diverted from a brain ventricle into the abdomen.
The approach can be used for several types of hydrocephalus.
However, the implanted system may become blocked or infected.
Some children require additional operations to repair or replace shunt components.
ETV avoids dependence on a permanent shunt in successful cases.
Yet the surgically created opening can close or fail to provide adequate drainage.
Both approaches require follow-up.
Why age and cause matter
ETV outcomes vary with age and the underlying condition.
Very young infants often have lower ETV success rates than older children with favorable anatomy.
Post-hemorrhagic hydrocephalus can be especially challenging because fluid absorption may also be impaired.
Some centers consider ETV combined with choroid plexus cauterization in selected infants.
This additional procedure aims to reduce CSF production.
Its suitability and expected benefit depend on the individual case and the treating team's expertise.
Understanding treatment risks
Every brain operation carries risks.
Potential complications include bleeding, infection, injury to nearby structures, and failure to control hydrocephalus.
VP shunts carry device-related risks.
ETV carries the possibility that the opening will close or fail.
Importantly, ETV failure can sometimes occur after a period of successful treatment.
A child with concerning symptoms needs urgent assessment regardless of which procedure was performed.
How families can discuss treatment choices
Parents can ask the neurosurgical team why a particular procedure is recommended.
Useful topics include the underlying cause of hydrocephalus, expected treatment success, and follow-up requirements.
The team can also explain what symptoms require emergency care.
There is no universal best procedure.
A treatment that is appropriate for one child may not be suitable for another.
Local spotlight: Ongoing pediatric care
Children treated for hydrocephalus benefit from continuity of care.
Maintaining imaging reports, surgical records, and emergency instructions can help new clinicians understand the child's history.
This is especially useful when families relocate or change healthcare providers.
Common questions around ETV and shunts
Is ETV better than a VP shunt?
Not universally. Suitability depends on age, anatomy, and the cause of hydrocephalus.
Does ETV eliminate the need for follow-up?
No. ETV can fail, sometimes after an extended period.
Can a baby receive ETV after a brain bleed?
Selected infants may be evaluated for ETV, but success rates vary and other procedures may be more appropriate.
